Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPE [AMEX]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.07 Insider Own0.40% Shs Outstand178.62M Perf Week-22.70%
Market Cap261.50M Forward P/E- EPS next Y-0.08 Insider Trans0.00% Shs Float170.95M Perf Month-20.56%
Income-12.30M PEG- EPS next Q-0.02 Inst Own15.70% Short Float12.59% Perf Quarter55.43%
Sales- P/S- EPS this Y-122.50% Inst Trans30.68% Short Ratio2.86 Perf Half Y99.72%
Book/sh0.06 P/B23.83 EPS next Y11.10% ROA-97.90% Target Price- Perf Year132.52%
Cash/sh0.05 P/C27.82 EPS next 5Y- ROE-192.90% 52W Range0.31 - 2.98 Perf YTD-10.06%
Dividend- P/FCF- EPS past 5Y29.60% ROI- 52W High-52.01% Beta1.75
Dividend %- Quick Ratio5.60 Sales past 5Y- Gross Margin- 52W Low361.29% ATR0.22
Employees23 Current Ratio5.60 Sales Q/Q- Oper. Margin- RSI (14)38.43 Volatility10.64% 11.96%
OptionableYes Debt/Eq0.00 EPS Q/Q62.80% Profit Margin- Rel Volume0.45 Prev Close1.65
ShortableYes LT Debt/Eq0.00 EarningsMar 03 AMC Payout- Avg Volume7.53M Price1.43
Recom2.00 SMA20-26.82% SMA50-20.17% SMA20035.96% Volume3,591,937 Change-13.33%
Dec-19-19Initiated ROTH Capital Buy $4
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Mar-04-21 01:30AM  
Mar-03-21 04:01PM  
02:30PM  
09:15AM  
Feb-24-21 09:15AM  
Feb-23-21 09:15AM  
Feb-16-21 09:15AM  
Feb-01-21 09:15AM  
Jan-14-21 09:15AM  
Jan-04-21 09:15AM  
Dec-29-20 03:59PM  
09:15AM  
Dec-23-20 03:33PM  
Dec-17-20 09:15AM  
Dec-15-20 08:56AM  
Dec-10-20 09:15AM  
Dec-08-20 09:15AM  
Dec-02-20 09:15AM  
Dec-01-20 08:44AM  
Nov-25-20 09:15AM  
Nov-17-20 09:15AM  
Nov-16-20 11:15PM  
Nov-10-20 04:01PM  
Nov-05-20 03:45PM  
Nov-02-20 09:15AM  
Oct-28-20 07:30AM  
Oct-27-20 09:15AM  
Oct-26-20 09:15AM  
Oct-08-20 09:15AM  
Sep-21-20 09:15AM  
Sep-14-20 09:15AM  
Sep-09-20 09:15AM  
Sep-04-20 09:15AM  
Aug-19-20 08:00AM  
Jul-31-20 02:43PM  
Jul-23-20 08:00AM  
Jul-20-20 08:00AM  
Jun-29-20 11:31AM  
Jun-19-20 08:00AM  
May-22-20 08:00AM  
May-21-20 06:45AM  
May-11-20 08:00AM  
Apr-16-20 08:37AM  
Apr-02-20 10:41AM  
09:00AM  
Mar-24-20 07:00AM  
06:30AM  
Feb-21-20 06:30AM  
Dec-23-19 07:57PM  
Dec-04-19 08:30AM  
Oct-10-19 08:30AM  
Sep-18-19 08:30AM  
Sep-17-19 08:30AM  
Aug-22-19 08:30AM  
Jul-25-19 08:30AM  
Jul-11-19 08:30AM  
Jul-10-19 08:30AM  
Jun-19-19 04:01PM  
Jun-17-19 08:16AM  
Jun-14-19 04:01PM  
07:30AM  
May-22-19 08:30AM  
Apr-29-19 08:00AM  
Mar-26-19 07:34PM  
Mar-06-19 08:30AM  
Feb-25-19 07:40AM  
Feb-06-19 08:30AM  
Dec-13-18 06:00AM  
Nov-26-18 08:30AM  
Nov-07-18 04:45PM  
08:30AM  
Oct-30-18 12:23PM  
Oct-25-18 08:55AM  
Oct-24-18 03:10PM  
12:00PM  
Oct-23-18 04:33PM  
03:55PM  
11:55AM  
10:00AM  
Oct-22-18 05:10PM  
04:25PM  
01:15PM  
11:40AM  
Oct-21-18 10:30PM  
06:00PM  
02:00PM  
11:00AM  
Oct-20-18 01:50PM  
07:00AM  
Oct-19-18 06:26PM  
05:05PM  
05:00PM  
02:20PM  
01:24PM  
12:01PM  
10:29AM  
Oct-18-18 03:15PM  
11:31AM  
Oct-17-18 04:25PM  
03:07PM  
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. has collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion. The company is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STOKELY DANCFOFeb 12Option Exercise2.5552,500133,87552,500Feb 17 02:51 PM